Relmada Therapeutics, Inc. (RLMD): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-5, first reflected in a filing dated 2015-09-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

39.48M
Year ended 2025-12-31
+10.0%
3-year compound annual growth
2021-12-31: 17.55M2022-12-31: 29.63M2023-12-31: 30.10M2024-12-31: 30.16M2025-12-31: 39.48M39.48M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3139.48M+30.9%2026-03-19, From 2025-01-01
2024-12-3130.16M+0.2%2026-03-19, From 2024-01-01
2023-12-3130.10M+1.6%2025-03-27, From 2023-01-01
2022-12-3129.63M+68.8%2024-03-19, From 2022-01-01
2021-12-3117.55Mn/a2023-03-23, From 2021-01-01